Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Biowatch
Home
>
Biowatch
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by maintaining kidney function over a...
08/12/2026, 23:23 ET
Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half
Celltrion Group Chairman Seo Jung-jin will forgo his summer vacation this August to embark on an intensive overseas tour across Europe, North...
08/12/2026, 23:19 ET
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation
Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
08/12/2026, 11:04 ET
Queasy Using Your Phone in the Car? iPhone’s Moving Dots May Help Curb Motion Sickness
Looking at an electronic device such as a smartphone or tablet inside a moving vehicle can quickly trigger motion...
08/10/2026, 10:45 ET
Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares
The "four-party alliance" formed to stabilize management control at Hanmi Pharmaceutical Group has descended into open...
08/09/2026, 11:02 ET
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...
08/09/2026, 10:45 ET
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption
Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
08/09/2026, 10:45 ET
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
08/09/2026, 09:45 ET
HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use
HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of...
08/09/2026, 09:44 ET
Suwon Nanuri Hospital Offers Free Spine and Joint Consultations for Foreign Workers
Foreign workers living in South Korea and their families often struggle to access healthcare when suffering from spine...
08/09/2026, 09:23 ET
Previous
3
4
5
6
7
Next